Related Experiment Videos
Studies with live attenuated influenza virus in chronic bronchitis
Thorax
|December 1, 1977
Summary
Live recombinant virus immunisation for influenza caused severe respiratory illnesses in patients with chronic obstructive airways disease. These individuals are more susceptible, requiring special care during future vaccine trials.
Area of Science:
- Immunology
- Virology
- Pulmonology
Background:
- Chronic obstructive airways disease (COPD) patients exhibit increased susceptibility to respiratory infections.
- Live recombinant virus vaccines are a novel approach for influenza immunization.
Purpose of the Study:
- To evaluate the safety and efficacy of live recombinant virus influenza immunisation in patients with COPD.
- To identify potential risks associated with this vaccination strategy in a vulnerable population.
Main Methods:
- Administration of live recombinant virus influenza vaccine to patients with COPD.
- Monitoring for the development of respiratory illnesses and adverse events.
Main Results:
- A significant incidence of respiratory illnesses, including severe cases, was observed in COPD patients post-vaccination.
- COPD patients demonstrated heightened susceptibility to the influenza virus compared to healthy individuals.
Conclusions:
- Live recombinant virus influenza vaccines may pose risks for patients with chronic obstructive airways disease.
- Specialized precautions and careful clinical evaluation are essential when testing such vaccines in individuals with respiratory conditions.